CSR Pharmacology & Drug-Nutrient Interactions in Renal Disease Flashcards
6 cards from real CSR practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 6 CSR Pharmacology & Drug-Nutrient Interactions in Renal Disease flashcards as text
Which phosphate binder is calcium-based and commonly used to manage hyperphosphatemia in CKD patients?
Answer: Calcium acetate
Calcium acetate is a calcium-based phosphate binder used to control hyperphosphatemia in CKD patients.
Which antihypertensive drug class can significantly increase serum potassium by reducing aldosterone secretion in CKD patients?
Answer: ACE inhibitors
ACE inhibitors reduce aldosterone secretion, leading to potassium retention and increased hyperkalemia risk in CKD.
Sevelamer is preferred over calcium-based phosphate binders in CKD patients who have which condition?
Answer: Hypercalcemia or vascular calcification
Sevelamer is preferred when calcium-based binders may worsen hypercalcemia or contribute to vascular calcification.
Which vitamin supplement requires active-form supplementation in CKD due to impaired renal 1-alpha hydroxylation?
Answer: Calcitriol (active vitamin D)
CKD impairs renal 1-alpha hydroxylation of vitamin D, requiring supplementation with its active form, calcitriol.
Loop diuretics in CKD patients may increase risk of which electrolyte deficiency due to increased urinary losses?
Answer: Hypomagnesemia
Loop diuretics increase urinary magnesium excretion, predisposing CKD patients to hypomagnesemia.
Erythropoiesis-stimulating agents (ESAs) used for anemia in CKD require adequate stores of which nutrient for efficacy?
Answer: Iron
ESAs stimulate red blood cell production but require sufficient iron stores to support erythropoiesis effectively.